CVE-2011-3386

N/A Unknown
Published: September 02, 2011 Modified: April 29, 2026
View on NVD

Description

Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device's serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011. NOTE: the vendor has disputed the severity of this issue, saying "we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low... we strongly believe it would be extremely difficult for a third-party to wirelessly tamper with your insulin pump... you would be able to detect tones on the insulin pump that weren't intentionally programmed and could intervene accordingly."

AI Explanation

Get an AI-powered plain-language explanation of this vulnerability and remediation steps.

Login to generate AI explanation

References to Advisories, Solutions, and Tools

Patch Vendor Advisory Exploit Third Party Advisory
http://www.loop-blog.com/Blog_Full_Post?id=a09C000000Dbz3JIAR
Source: af854a3a-2127-422b-91ae-364da2661108
https://exchange.xforce.ibmcloud.com/vulnerabilities/69643
Source: af854a3a-2127-422b-91ae-364da2661108

16 reference(s) from NVD

Quick Stats

CVSS v3 Score
N/A / 10.0
EPSS (Exploit Probability)
1.5%
70th percentile
Exploitation Status
Not in CISA KEV

Affected Vendors

medtronic